ISB News

Science, Tech, Design & Food Converge at reThinkFood Conference

ISB Associate Director Dr. Nathan Price participated in the panel discussion “Revolutions in Healthcare: Impacts on the Future of the Food Industry” during the reThinkFood conference at The Culinary Institute of America in Napa Valley. The panelists each gave a short talk about his/her respective interests and then sat down to a discussion. It was an interesting intersection of perspectives from Kevin Slavin (MIT Media Lab), Molly Maloof (Physician Entrepreneur), Ian Peikon (Google X), Nathan Price (ISB/Arivale) and Shireen Yates (6SensorLabs).

Recent Articles

  • Co-corresponding author and ISB President Dr. Jim Heath and co-lead author Dr. Yapeng Su.

    For Cancer Cells, There Is More Than One Path to Drug Resistance

    In findings published in the journal Nature Communications, researchers show that cancer cells can take more than one path to reach a drug-resistant cell state. These findings could have promising implications for the future of cancer care.

  • ISB researchers

    Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis

    ISB researchers have unveiled new insights on how Mycobacterium tuberculosis, the pathogen that causes tuberculosis, enters and exits a dormant state in human hosts. About a quarter of the world’s population has latent TB, so these important findings will enable and accelerate the discovery of more effective TB drugs.

  • Merck and ISB Collaborate to Understand and Treat SARS-CoV-2 Infection

    Merck is collaborating with ISB and its partners to analyze blood samples and nasal swabs from Swedish Medical Center patients with SARS-CoV-2. Blood samples will be examined using proteomic, metabolomic, transcriptomics and genetic techniques to evaluate the impact of infection on different organs, and to identify potential biomarkers to predict the risk of severe disease.